Company news
ANI Pharmaceuticals, Inc. news in 2021
ANI Pharmaceuticals, Inc.'s news releases, calls and decks from 2021, newest first.
ANI Pharmaceuticals Announces FDA Approval and Imminent Launch of Rifabutin Capsules USP
December 20, 2021
Eton Pharmaceuticals and ANI Pharmaceuticals Announce Commercial Availability of Carglumic Acid Tablets, the First and Only FDA-Approved Generic Version of Carbaglu® (carglumic acid)
December 19, 2021
ANI Pharmaceuticals to Present at the Piper Sandler 33rd Annual Healthcare Conference 2021
November 21, 2021
ANI Pharmaceuticals Completes Acquisition of Novitium Pharma, Significantly Enhancing R&D Capabilities and Scale of Generics and CDMO Businesses
November 21, 2021
ANI Pharmaceuticals Receives Clearance from U.S. Federal Trade Commission for the Acquisition of Novitium Pharma
November 10, 2021
ANI Pharmaceuticals, Inc. Announces Closing of $75 Million Public Offering of Common Stock
November 7, 2021
ANI Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
November 2, 2021
ANI Pharmaceuticals, Inc. Announces Pricing of $75 Million Public Offering of Common Stock
November 2, 2021
ANI Pharmaceuticals Reports Third Quarter 2021 Results
October 31, 2021
ANI Pharmaceuticals Announces FDA Approval of Purified Cortrophin™ Gel for Multiple Indications Including Multiple Sclerosis, Rheumatoid Arthritis and Nephrotic Syndrome
October 31, 2021
ANI Pharmaceuticals to Discuss Third Quarter 2021 Financial Results on November 1, 2021
October 28, 2021
ANI Pharmaceuticals to Present at Cantor Virtual Global Healthcare Conference 2021
September 19, 2021
ANI Pharmaceuticals Announces Launch of Nebivolol Tablets
September 16, 2021
ANI Pharmaceuticals Announces FDA Acceptance of Purified Cortrophin® Gel Supplemental New Drug Application for Multiple Indications Including Multiple Sclerosis, Rheumatoid Arthritis, and Nephrotic Syndrome
August 30, 2021
ANI Pharmaceuticals Reports Second Quarter 2021 Results
August 5, 2021
ANI Pharmaceuticals to Discuss Second Quarter 2021 Financial Results on August 6, 2021
July 21, 2021
ANI Pharmaceuticals Announces Refiling of Cortrophin sNDA with FDA
July 5, 2021
ANI Pharmaceuticals to Present at the Raymond James Human Health Innovation Conference 2021
June 14, 2021
ANI Pharmaceuticals Announces Details of 2021 Virtual Annual Meeting of Stockholders
May 31, 2021
ANI Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference 2021
May 26, 2021
ANI Pharmaceuticals Reports First Quarter 2021 Results
May 6, 2021
ANI Pharmaceuticals to Discuss First Quarter 2021 Financial Results on May 7, 2021
April 25, 2021
ANI Pharmaceuticals Expands Branded Products Portfolio Through Acquisition of Sandoz Inc. NDAs
April 5, 2021
ANI Pharmaceuticals to Acquire Novitium Pharma, Strengthening R&D Engine and Expanding Generics and CDMO Business
March 8, 2021
ANI Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Results; Company Positioned for Sustainable Future Growth
March 8, 2021
ANI Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 18, 2021
ANI Pharmaceuticals Strengthens Leadership Team to Accelerate Future Growth
February 16, 2021
ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2020 Financial Results on March 9, 2021
February 15, 2021
ANI Pharmaceuticals Announces Launch of Prazosin Hydrochloride (“HCl”) Capsules
January 31, 2021
Calls in 2021
Decks in 2021
- Jefferies Healthcare Conference June 2021
Conference · 14 slides · Jun 4, 2021